ProfileGDS5678 / 1452650_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 51% 48% 47% 48% 46% 50% 52% 52% 46% 47% 48% 47% 47% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2788351
GSM967853U87-EV human glioblastoma xenograft - Control 23.1355448
GSM967854U87-EV human glioblastoma xenograft - Control 33.1167947
GSM967855U87-EV human glioblastoma xenograft - Control 43.0896848
GSM967856U87-EV human glioblastoma xenograft - Control 53.0387746
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2819350
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3447352
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2547952
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0655346
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.088547
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1201848
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0634847
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1217647
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1445948